Acrivon Therapeutics, Inc. ACRV
Institutional shares held
18.2 Million
0
calls
0
puts
Total value of holdings
$0
$0
calls
$0
puts
Market Cap
N/A
Institutional ownership
N/A
# of Institutions
47
We take great care to ensure that the data presented and summarized in this overview for Acrivon Therapeutics, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding ACRV
View all-
Ra Capital Management, L.P. Boston, MA8.34MShares$00.0% of portfolio
-
Sands Capital Ventures, LLC Arlington, VA2.12MShares$00.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il1.54MShares$00.0% of portfolio
-
Wellington Management Group LLP Boston, MA888KShares$00.0% of portfolio
-
Black Rock Inc. New York, NY767KShares$00.0% of portfolio
-
Ubs Group Ag683KShares$00.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA626KShares$00.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny623KShares$00.0% of portfolio
-
Acorn Capital Advisors, LLC New York, NY405KShares$00.37% of portfolio
-
Two Sigma Investments, LP New York, NY319KShares$00.0% of portfolio
Latest Institutional Activity in ACRV
Top Purchases
Top Sells
About ACRV
Insider Transactions at ACRV
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 21
2025
|
Peter Blume Jensen President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
19,904
-0.96%
|
$39,808
$2.3 P/Share
|
|
Nov 14
2025
|
Eric Devroe Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
613
-0.93%
|
$1,226
$2.24 P/Share
|
|
Nov 14
2025
|
Erick Gamelin Chief Development Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
403
-2.57%
|
$806
$2.24 P/Share
|
|
Nov 14
2025
|
Mary Miller Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
184
-0.53%
|
$368
$2.24 P/Share
|
|
Nov 14
2025
|
Katharine Peterson Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
99
-2.35%
|
$198
$2.24 P/Share
|
|
Nov 14
2025
|
Peter Blume Jensen President and CEO |
SELL
Payment of exercise price or tax liability
|
Indirect |
490
-0.16%
|
$980
$2.24 P/Share
|
|
Nov 14
2025
|
Peter Blume Jensen President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
59,765
-2.81%
|
$119,530
$2.24 P/Share
|
|
Oct 17
2025
|
Mary Miller Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
558
-1.58%
|
$558
$1.81 P/Share
|
|
Oct 01
2025
|
Mary Miller Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
284
-0.8%
|
$284
$1.81 P/Share
|
|
Aug 21
2025
|
Peter Blume Jensen President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
19,905
-0.93%
|
$19,905
$1.32 P/Share
|
|
Aug 14
2025
|
Eric Devroe Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
613
-0.92%
|
$613
$1.39 P/Share
|
|
Aug 14
2025
|
Erick Gamelin Chief Development Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
403
-2.5%
|
$403
$1.39 P/Share
|
|
Aug 14
2025
|
Mary Miller Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
184
-0.51%
|
$184
$1.39 P/Share
|
|
Aug 14
2025
|
Katharine Peterson Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
99
-2.29%
|
$99
$1.39 P/Share
|
|
Aug 14
2025
|
Peter Blume Jensen President and CEO |
SELL
Payment of exercise price or tax liability
|
Indirect |
490
-0.16%
|
$490
$1.39 P/Share
|
|
Aug 14
2025
|
Peter Blume Jensen President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
59,766
-2.71%
|
$59,766
$1.39 P/Share
|
|
Aug 01
2025
|
Adam D. Levy Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,164
-8.74%
|
$1,164
$1.26 P/Share
|
|
Jul 17
2025
|
Mary Miller Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
558
-1.54%
|
$558
$1.32 P/Share
|
|
May 21
2025
|
Peter Blume Jensen President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
19,904
-0.89%
|
$19,904
$1.15 P/Share
|
|
May 14
2025
|
Mary Miller Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
184
-0.5%
|
$184
$1.14 P/Share
|
Last 12 Months Summary
Buy / Acquisition
0
Shares
From
0
Insiders
Sell / Disposition
2.56M
Shares
From
8
Insiders
| Open market or private sale | 2.26M shares |
|---|---|
| Payment of exercise price or tax liability | 308K shares |